11 results
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy - Initiation Strategies

 •
Heart Failure with ... ACE, ARB, ARNI → Beta-Blocker ... low-dose approach: Beta-Blocker ... #CHF #HFrEF #Guideline ... management #GDMT #cardiology
Heart Failure with Reduced Ejection Fraction (HFrEF) - Guideline Directed Medical Therapy
 • Beta-blocker
 • ACE,
Heart Failure with ... Guideline Directed Medical ... Therapy • Beta-blocker ... #CHF #HFrEF #Guideline ... management #GDMT #cardiology
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - ... Pharmacology Comparison ... in pt w/o CAD/HF ... #Blockers #Pharmacology ... #Receptors #cardiology
Target Doses in Congestive Heart Failure
 • Beta Blockers: Bisoprolol, Carvedilol, Metoprolol succinate, ARNI, Sacubitril/valsartan
 •
in Congestive Heart ... Failure • Beta ... Blockers: Bisoprolol ... #pharmacology # ... cardiology
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... pulmonary disease or CHF ... pulmonary disease or CHF ... Treatment #management #cardiology ... #algorithm
Recommended Therapeutic Approach to the Patient with Hypertrophic Cardiomyopathy (HOCM)
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers;
angiotensin receptor blockers ... ; HF, heart failure ... #HOCM #HcM #Hypertrophic ... Cardiomyopathy #Algorithm ... #Management #Cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker ... guideline-directed medical ... therapy; HF, heart ... #CHF #Congestive ... #Management #Cardiology
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Guideline-Directed Medical ... and an evidenced beta-blocker ... tolerated ACEI/ARB + Beta-Blocker ... #HFrEF #Pharmacology ... Treatment #StageC #Cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
increased bleed risk Beta-Blockers ... Decreases effects of beta-blockers ... hypertension and tachycardia ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Medical history ... disease b) CHF ... event, follow ACC algorithm ... one post op Cardiology ... perioperative medical